Medicine
NuvaRing 0.015 mg/0.12 mg per day extended-release vaginal insert
NuvaRing 0.015 mg/0.12 mg per day extended-release vaginal insert is a prescription medicine containing Ethinyl estradiol and Etonogestrel for vaginal use, marketed by Organon, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Prior to dispensing to the user, store refrigerated 2°C to 8°C (36°F to 46°F)…
Key facts
- Active ingredient (INN)
- Ethinyl estradiol and Etonogestrel
- Brand
- NuvaRing
- Strength
- 0.015 mg/0.12 mg per day
- Dosage form
- Extended-release vaginal insert
- Route
- Vaginal
- Packs
- 3 pouches, 1 pouch and 1 more
- Marketing authorisation holder
- Organon
- Manufacturers
- OrganonA-S Medication SolutionsAdvanz Pharma
- Origin register
- US FDA, United States
- Storage
- Prior to dispensing to the user, store refrigerated 2°C to 8°C (36°F to 46°F). After dispensing to the user, NuvaRing can be stored for up to 4 months at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Avoid storing NuvaRing in direct sunlight or at temperatures above 30°C (86°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 June 2021
- Identifiers
- RxCUI 1367436, 1367439DailyMed set ID 524c7188-ee84-4d5c-a6ab-e7a5ae36e22b, e14bc197-dd22-4e6e-8aa1-d6cf2242fe0f, 55eb60e3-6f4d-40a3-8ee6-e7fd2d0c7d97 +1NDC 50090-7663, 50090-5611, 78206-146 +1Application NDA021187
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 3 pouch in 1 box / 21 d in 1 pouch | 78206-146-03 | Organon | 1 June 2021 |
| 3 pouch in 1 box / 21 d in 1 pouch | 59212-146-03 | Advanz Pharma | 19 May 2025 |
| 3 pouch in 1 box / 21 d in 1 pouch | 50090-5611-0 | A-S Medication Solutions | 12 August 2021 |
| 1 pouch in 1 box / 21 d in 1 pouch | 50090-7663-0 | A-S Medication Solutions | 30 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 October 2001 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Ethinyl estradiol and Etonogestrel 0.015 mg/0.12 mg per day extended-release vaginal insert.
Other strengths and forms of Ethinyl estradiol and Etonogestrel
Clinical summary
Ethinyl estradiol and Etonogestrel is a fixed-dose combination of an estrogen and a progestin indicated by females of reproductive age to prevent pregnancy. It is available as extended-release vaginal inserts and vaginal rings. MedsAcross supplies Ethinyl estradiol and Etonogestrel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Ethinyl estradiol and EtonogestrelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- NuvaRing prescribing information (Organon) · U.S. National Library of Medicine, DailyMed
Need NuvaRing 0.015 mg/0.12 mg per day extended-release vaginal insert for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.